예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>아시아 태평양 엑소솜 연구 제품 시장, 제품별(기기 및 소모품), 적응증(암 및 비암), 응용 분야(치료 및 진단), 최종 사용자(병원, 임상 시험 연구소, 연구 센터, 제약 및 생명 공학 회사, 학술 기관 및 기타), 유통 채널(제3자 유통업체, 온라인 및 직접 입찰) 산업 동향 및 2030년까지의 예측.
아시아 태평양 엑소솜 연구 제품 시장 분석 및 통찰력
암과 다양한 자가면역 질환의 유병률과 발생률이 증가함에 따라 시장 수요가 증가했습니다. 주요 시장 참여자들은 이 중요한 기간 동안 다양한 서비스 출시와 승인에 집중합니다. 또한 제약 R&D와 생명 과학 연구에 대한 투자 증가도 엑소좀 연구 제품 테스트에 대한 수요 증가에 기여합니다.
아시아 태평양 엑소솜 연구 제품 시장은 시장 참여자의 증가와 고급 서비스의 가용성으로 인해 예측 연도에 성장할 것으로 예상됩니다. 이와 함께 제조업체는 시장에서 새로운 서비스를 출시하기 위한 R&D 활동에 참여하고 있습니다.
그러나 엑소좀을 개발하고 생산하기 위한 골드 스탠다드 프로토콜이 부족하면 예측 기간 동안 아시아 태평양 엑소좀 연구 제품 시장의 성장이 방해받을 수 있습니다.
엑소솜 기술의 급속한 발전으로 시장에서 치료를 개선할 수 있는 기회가 창출될 것으로 기대됩니다.
그러나 엑소좀 연구 제품과 관련된 부작용과 제품 출시와 관련된 늦은 승인은 시장 성장에 어려움을 줄 수 있습니다.
Data Bridge Market Research는 아시아 태평양 엑소좀 연구 제품 시장이 2030년까지 5,68,432.59천 달러에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 40.3%가 될 것으로 분석했습니다. 진단 및 치료 분야에서 엑소좀 연구 제품의 사용이 증가함에 따라 제품은 시장에서 가장 큰 유형 세그먼트를 차지합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 |
|
양적 단위 |
매출은 천 달러, 볼륨은 단위, 가격은 달러로 표시 |
|
다루는 세그먼트 |
제품별(기구 및 소모품), 적응증(암 및 비암), 응용 분야(치료 및 진단), 최종 사용자(병원, 임상 시험 연구소, 연구 센터, 제약 및 생명 공학 회사, 학술 기관 및 기타), 유통 채널(제3자 유통업체, 온라인 및 직접 입찰) |
|
적용 국가 |
중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 베트남 및 아시아 태평양의 나머지 지역 |
|
시장 참여자 포함 |
아시아 태평양 엑소솜 연구 제품 시장의 주요 기업으로는 Hologic Inc., Luminex Corporation, Thermo Fisher Scientific, Agilent Technologies, Inc., Microgentas, Cell Guidance Systems LLC, QIAGEN, FUJIFILM Irvine Scientific(FUJIFILM Holdings Corporation의 자회사), CUSABIO TECHNOLOGY LLC, Norgen Biotek Corp., Miltenyi Biotec, Novus Biologicals, Beckman Coulter, Inc., JSR Micro NV, Hitachi, Ltd., INOVIQ, Audubon Bioscience 등이 있습니다. |
아시아 태평양 엑소좀 연구 제품 시장 정의
엑소좀은 엔도솜으로 구성된 세포 유래 세포외 소포의 특정 종류이며 일반적으로 직경이 30-150nm로 가장 작은 유형의 세포외 소포입니다. 지질 이중층으로 보호되는 엑소좀은 세포 외 환경으로 밀려나 원래 세포에서 유래된 복잡한 화물을 포함합니다. 화물에 존재하는 내용물은 단백질, 지질 , 메신저 리보핵산(mRNA), 미세소체 리보핵산(miRNA), 데옥시리보핵산(DNA)입니다.
엑소좀은 자가면역 질환과 같은 다양한 만성 질환을 치료하는 데 사용되었습니다. 엑소좀 치료제는 약물 전달, 종양 면역 요법 및 진단 바이오마커에 널리 사용되었습니다. 엑소좀은 크기가 작고, 본래의 특성이며, 생물학적 장벽을 넘을 수 있는 능력 때문에 약물 운반체로 사용됩니다.
아시아 태평양 엑소솜 연구 제품 시장 동향
이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 암, 만성 염증, 자가면역 질환, 라임병 및 기타 만성 퇴행성 질환의 유병률 증가
WHO에 따르면 암은 전 세계적으로 사망의 주요 원인으로, 2020년에 약 1,000만 명이 사망했습니다. 인도의 남성 암 환자 수는 2020년에 약 679,421명이었고, 여성의 경우 약 712,758명이었습니다. 2021년의 새로운 암 사례와 사망자 수는 약 190만 명이었고, 미국에서 암으로 인한 사망자는 608,570명이었습니다. 따라서 암 발병률은 연구자들이 점점 더 많은 연구를 하도록 격려하고 있으며, 바이오마커는 암을 식별하는 데 도움이 됩니다. 따라서 시장 성장이 증가합니다.
따라서 결론적으로 심혈관계 질환, 신경계 질환 및 기타 다양한 만성 질환과 같은 만성 질환의 증가는 다양한 의약품에 대한 수요를 증가시켰으며, 이는 향후 몇 년 동안 아시아 태평양 엑소좀 연구 제품 시장의 성장을 촉진할 것입니다.
- 제약 R&D 및 생명과학 연구 투자 증가
학술 및 연구 기관, 제약 및 생명공학 기업, 병원, 임상 시험 실험실이 시장의 주요 최종 사용자입니다. 최근 몇 년 동안 질병 탐지 잠재력과 세포 간 메신저로서의 새로운 역할로 인해 엑소솜 연구에 대한 수요가 증가했습니다. 이는 여러 학술 연구자들의 관심을 끌어 시장 성장으로 이어졌습니다. 2022년 제약 R&D 지출 추세에 따르면 현재 전 세계적으로 6,000개 이상의 품목이 임상 시험에서 조사되고 있으며, 이는 2016년 대비 68% 증가한 수치입니다.
시장 참여자들이 끊임없이 연구 및 개발 활동에 참여함에 따라 아시아 태평양 엑소좀 연구 제품 시장에 더 많은 하이브리드 및 천연 엑소좀이 도입되고 있습니다. 이는 병원 및 진단 센터에서 암과 자가면역 질환을 치료하기 위한 엑소좀 치료제에 대한 수요를 증가시킬 것입니다. 따라서 연구 개발 활동의 발전과 제약 부문에 대한 투자 증가가 전반적인 시장 성장을 촉진할 것으로 예상됩니다.
제지
- 엑소좀 개발 및 생산을 위한 금본위 프로토콜 부족
엑소좀 분야는 아직 초기 단계에 있으며, 지금까지 금본위제도 개발되지 않았습니다. 따라서 전문가들은 주저 없이 시장에서 새로운 절차와 방법론을 채택합니다. 연구자들이 엑소좀 생산 중에 실수를 하는 것 외에도, 과학자들은 엑소좀 연구 개발 및 제조 활동에서 다양한 어려움에 직면합니다.
엑소좀의 인증 및 안전성 부족은 안전 프로토콜과 천연 및 하이브리드 엑소좀의 생산을 방해할 것입니다. 따라서 엑소좀을 개발하는 데 있어 표준 프로토콜이 부족하고 엑소좀을 분리하기 위한 인증 요건이 없는 것은 엑소좀 연구 제품 시장의 성장을 제한할 것으로 예상됩니다.
기회
-
최종 사용자 사이에서 전문 테스트 서비스에 대한 수요 증가
엑소좀은 정교한 RNA와 단백질을 함유한 작은(30~150nm) 소포로, 시험관 내와 생체 내 모든 세포에서 끊임없이 분비됩니다. 엑소좀은 세포 간 통신과 신호 전달을 포함하여 인체 내에서 흥미로운 기능으로 인해 연구를 변화시키고 있습니다.
그 이후로 액체 크로마토그래피-질량 분석법, RNA 시퀀싱, 습식 화학, 유전자 발현 및 기타 다양한 테스트 서비스와 같은 전문적인 테스트 서비스의 사용이 증가함에 따라 엑소좀 연구 제품 시장이 성장하고 이러한 테스트 서비스가 정밀하고 정확한 결과를 제공할 수 있는 능력이 향상되어 최종 사용자의 수요가 증가했습니다.
도전
- 엑소좀 연구제품과 관련된 부작용
모든 의료 치료에는 이점과 위험이 있지만, 승인되지 않은 엑소솜 제품은 명확한 이점 없이 환자를 잠재적 위험에 노출시킵니다. 이러한 제품은 잠재적으로 많은 의학적 상태와 질병을 치료할 수 있지만, 제품에 이점이 있는지 또는 사용하기에 안전한지 알아보려면 추가 연구가 필요합니다. 부작용에는 주사 부위 반응, 예상대로 세포가 작동하지 않는 것, 종양 성장, 감염, 제품 오염 가능성, 세포가 배치 부위에서 이동하여 부적절한 세포 유형으로 증식하거나 변하는 능력이 포함될 수 있습니다.
앞으로 아시아태평양 엑소좀 연구제품 시장은 진단 시 안전성, 비용, 편의성 측면에서 엑소좀 연구제품의 다양한 부작용이 문제로 대두될 것으로 예상된다.
최근 개발 사항
- 2022년 7월, 암과 생명을 위협하는 감염병의 진단 및 치료를 위한 제품 개발에 중점을 둔 의료 치료 회사인 Aethlon Medical, Inc.는 미국 식품의약국(FDA)이 중증 COVID-19 환자를 대상으로 진행 중인 Aethlon Hemopurifier의 임상 시험에 대한 프로토콜 수정안을 승인했다고 발표했습니다.
- 2020년 4월, ExoDX는 전립선 건강에 대해 걱정하는 환자를 위해 ExoDx 전립선 검사 홈 수집 키트를 출시했습니다. 홈 수집 키트는 진행성 전립선암 환자의 좌절, 불안 및 두려움을 공유하는 의사와 환자에게 원격 진료/원격 건강 옵션을 제공하는 즉각적이고 비용 효율적인 솔루션을 제공합니다.
아시아 태평양 엑소솜 연구 제품 시장 범위
아시아 태평양 엑소솜 연구 제품 시장은 제품, 적응증, 응용 분야, 최종 사용자, 유통 채널 등 5가지 주요 세그먼트로 세분화됩니다. 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
제품별 아시아 태평양 엑소좀 연구 제품 시장
- 악기
- 소모품
아시아 태평양 엑소솜 연구 제품 시장은 제품을 기준으로 장비와 소모품으로 구분됩니다.
아시아 태평양 엑소좀 연구 제품 시장, 지표별
- 암
- 비암
아시아 태평양 엑소좀 연구 제품 시장은 지표를 기준으로 암 분야와 비암 분야로 구분됩니다.
아시아 태평양 엑소좀 연구 제품 시장, 응용 분야별
- 치료학
- 진단
아시아 태평양 엑소솜 연구 제품 시장은 응용 분야를 기준으로 치료제와 진단제로 구분됩니다.
최종 사용자별 아시아 태평양 엑소좀 연구 제품 시장
- 병원
- 임상 테스트 실험실
- 연구 센터
- 제약 및 생명공학 회사
- 학술 기관
- 기타
아시아 태평양 엑소솜 연구 제품 시장은 최종 사용자를 기준으로 병원, 임상 시험 연구소, 연구 센터, 제약 및 생명 공학 회사, 학술 기관 등으로 구분됩니다.
아시아 태평양 엑소좀 연구 제품 시장, 유통 채널별
- 제3자 유통업체
- 온라인
- 직접 입찰
아시아 태평양 엑소솜 연구 제품 시장은 유통 채널을 기준으로 제3자 유통업체, 온라인, 직접 입찰로 구분됩니다.
아시아 태평양 엑소솜 연구 제품 시장 지역 분석/통찰력
아시아 태평양 엑소좀 연구 제품 시장은 제품, 적응증, 응용 분야, 최종 사용자, 유통 채널 등 5가지 주요 부문으로 분류됩니다.
이 시장 보고서에 포함된 국가로는 중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 베트남, 그리고 나머지 아시아 태평양 지역이 있습니다.
중국은 R&D 투자 증가로 인해 아시아 태평양 지역을 주도할 것으로 예상되며, 이를 통해 시장 성장이 촉진될 것으로 기대됩니다.
보고서의 국가 섹션은 또한 시장의 현재 및 미래 추세에 영향을 미치는 개별 시장 영향 요인과 국내 규제 변경 사항을 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제와 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 아시아 태평양 엑소솜 연구 제품 시장 점유율 분석
아시아 태평양 엑소좀 연구 제품 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선입니다. 위의 데이터 포인트는 아시아 태평양 엑소좀 연구 제품 시장에 대한 회사의 초점에만 관련이 있습니다.
아시아 태평양 엑소솜 연구 제품 시장의 주요 기업으로는 Hologic Inc., Luminex Corporation, Thermo Fisher Scientific, Agilent Technologies, Inc., Microgentas, Cell Guidance Systems LLC, QIAGEN, FUJIFILM Irvine Scientific(FUJIFILM Holdings Corporation의 자회사), CUSABIO TECHNOLOGY LLC, Norgen Biotek Corp., Miltenyi Biotec, Novus Biologicals, Beckman Coulter, Inc., JSR Micro NV, Hitachi, Ltd., INOVIQ, Audubon Bioscience 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 SUPPLY CHAIN ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 BUSINESS STRATEGY EXCELLENCE
4.6 CASE STUDIES
4.7 STRENGTH OF PRODUCT PORTFOLIO
4.8 TECHNOLOGICAL TRENDS
4.9 PRICING ANALYSIS
5 INDUSTRY INSIGHTS
6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES
7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH
7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME
7.2 RESTRAINTS
7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES
7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME
7.3 OPPORTUNITIES
7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS.
7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS
7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES
8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CONSUMABLES
8.2.1 KITS AND REAGENTS
8.2.1.1 EXOSOME BIOMARKER KITS
8.2.1.2 EXOSOME ISOLATION KITS
8.2.1.3 EXOSOME PURIFICATION KITS
8.2.1.4 EXOSOME QUANTITATIVE KITS
8.2.1.5 EXOSOME DETECTION KITS
8.2.1.6 OTHERS
8.2.2 EXOSOME STANDARDS
8.2.3 EXOSOME ANTIBODIES
8.2.4 CELL LINES
8.2.5 IMMUNOPLATES
8.2.6 IMMUNOBEADS
8.2.7 BIOFLUIDS
8.2.8 OTHERS
8.3 INSTRUMENTS
8.3.1 BENCHTOP
8.3.2 STANDALONE
9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
9.1 OVERVIEW
9.2 CANCER
9.2.1 LUNG CANCER
9.2.2 BREAST CANCER
9.2.3 COLORECTAL CANCER
9.2.4 PROSTATE CANCER
9.2.5 OTHER CANCER
9.3 NON-CANCER
9.3.1 CARDIOVASCULAR DISEASE
9.3.2 NEURODEGENERATIVE DISEASE
9.3.3 INFECTIOUS DISEASE
9.3.4 OTHERS
10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION
10.1 OVERVIEW
10.2 THERAPEUTICS
10.3 CONSUMABLES
10.4 INSTRUMENTS
10.5 DIAGNOSIS
10.6 CONSUMABLES
10.7 INSTRUMENTS
11 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
11.3 CONSUMABLES
11.4 INSTRUMENTS
11.5 RESEARCH CENTRES
11.6 CONSUMABLES
11.7 INSTRUMENTS
11.8 ACADEMIC INSTITUTES
11.9 CONSUMABLES
11.1 INSTRUMENTS
11.11 CLINICAL TESTING LABORATORY
11.12 CONSUMABLES
11.13 INSTRUMENTS
11.14 HOSPITALS
11.15 CONSUMABLES
11.16 INSTRUMENTS
11.17 OTHERS
12 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 THIRD PARTY DISTRIBUTORS
12.3 DIRECT SALES
12.4 ONLINE
13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 NEW ZEALAND
13.1.12 VIETNAM
13.1.13 TAIWAN
13.1.14 REST OF ASIA-PACIFIC
14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 EXODX (ACQUIRED BY BIO-TECHNE)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 MILTENYI BIOTEC
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 LUMINEX CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENT
16.5 HOLOGIC, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AETHLON MEDICAL, INC. (2022)
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 AGILENT TECHNOLOGIES, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 AMSBI0
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 AUDUBON BIOSCIENCE.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC)
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 COMPANY SHARE ANALYSIS
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENT
16.12 CELL GUIDANCE SYSTEMS LLC
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 CREATIVE BIOARRAY
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 CUSABIO TECHNOLOGY LLC
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 HBMLS (ACQUIRED BY LONZA)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 HITACHI, LTD.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 INOVIQ
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 JSR MICRO NV
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 MICROGENTAS
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 NANOSOMIX
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 NEXOSOME-ONCOLOGY
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 NORGEN BIOTEK CORP.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NOVUS BIOLOGICALS
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 PROTEOGENEX
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 QIAGEN
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 ROOSTERBIO, INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 SYSTEM BIOSCIENCES, LLC.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS
TABLE 2 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND)
TABLE 3 ASIA PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 ASIA PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 5 ASIA PACIFIC KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 6 ASIA PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 ASIA PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 9 ASIA PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 ASIA PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 11 ASIA PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 ASIA PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 14 ASIA PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 ASIA PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 16 ASIA PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 ASIA PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 19 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 21 ASIA PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 ASIA PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 23 ASIA PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 ASIA PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 25 ASIA PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 ASIA PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 27 ASIA PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 ASIA PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 29 ASIA PACIFIC OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 31 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 ASIA PACIFIC DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 ASIA PACIFIC ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 52 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 53 CHINA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 54 CHINA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 55 CHINA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 56 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 57 CHINA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 58 CHINA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 59 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 60 CHINA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 61 CHINA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 62 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 63 CHINA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 64 CHINA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 65 CHINA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 66 CHINA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 67 CHINA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 69 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 70 JAPAN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 71 JAPAN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 72 JAPAN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 73 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 74 JAPAN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 75 JAPAN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 76 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 77 JAPAN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 JAPAN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 79 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 80 JAPAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 81 JAPAN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 82 JAPAN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 JAPAN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 84 JAPAN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 85 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 86 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 87 INDIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 88 INDIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 89 INDIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 90 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 91 INDIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 92 INDIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 93 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 94 INDIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 95 INDIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 96 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 97 INDIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 INDIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 99 INDIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 100 INDIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 101 INDIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 102 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 103 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 104 SOUTH KOREA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 105 SOUTH KOREA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 106 SOUTH KOREA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 107 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 108 SOUTH KOREA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 109 SOUTH KOREA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 110 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 111 SOUTH KOREA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 112 SOUTH KOREA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 113 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 114 SOUTH KOREA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 115 SOUTH KOREA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 116 SOUTH KOREA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 117 SOUTH KOREA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 118 SOUTH KOREA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 119 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 120 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 121 AUSTRALIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 122 AUSTRALIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 123 AUSTRALIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 124 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 125 AUSTRALIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 126 AUSTRALIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 127 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 128 AUSTRALIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 129 AUSTRALIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 130 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 131 AUSTRALIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 132 AUSTRALIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 133 AUSTRALIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 134 AUSTRALIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 135 AUSTRALIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 136 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 137 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 138 SINGAPORE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 139 SINGAPORE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 140 SINGAPORE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 141 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 142 SINGAPORE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 143 SINGAPORE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 144 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 145 SINGAPORE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 146 SINGAPORE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 147 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 148 SINGAPORE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 149 SINGAPORE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 150 SINGAPORE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 151 SINGAPORE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 152 SINGAPORE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 154 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 155 MALAYSIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 156 MALAYSIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 157 MALAYSIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 158 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 159 MALAYSIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 160 MALAYSIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 161 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 162 MALAYSIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 163 MALAYSIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 164 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 165 MALAYSIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 166 MALAYSIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 167 MALAYSIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 168 MALAYSIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 MALAYSIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 170 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 171 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 172 THAILAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 173 THAILAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 174 THAILAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 175 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 176 THAILAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 177 THAILAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 178 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 179 THAILAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 180 THAILAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 181 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 182 THAILAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 THAILAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 184 THAILAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 THAILAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 186 THAILAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030
TABLE 187 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 188 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 189 INDONESIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 190 INDONESIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 191 INDONESIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 192 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 193 INDONESIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 194 INDONESIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 195 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 196 INDONESIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 197 INDONESIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 198 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 199 INDONESIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 200 INDONESIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 INDONESIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 202 INDONESIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 203 INDONESIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 204 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 205 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 206 PHILIPPINES CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 207 PHILIPPINES KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 208 PHILIPPINES INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 209 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 210 PHILIPPINES CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 211 PHILIPPINES NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 212 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 213 PHILIPPINES THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 214 PHILIPPINES DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 215 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 216 PHILIPPINES PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 217 PHILIPPINES RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 PHILIPPINES ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 219 PHILIPPINES CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 220 PHILIPPINES HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 221 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 222 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 223 NEW ZEALAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 224 NEW ZEALAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 225 NEW ZEALAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 226 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 227 NEW ZEALAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 228 NEW ZEALAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 229 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 230 NEW ZEALAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 231 NEW ZEALAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 232 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 233 NEW ZEALAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 234 NEW ZEALAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 235 NEW ZEALAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 236 NEW ZEALAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 237 NEW ZEALAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 238 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 239 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 240 VIETNAM CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 241 VIETNAM KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 242 VIETNAM INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 243 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 244 VIETNAM CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 245 VIETNAM NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 246 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 247 VIETNAM THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 248 VIETNAM DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 249 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 250 VIETNAM PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 251 VIETNAM RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 252 VIETNAM ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 253 VIETNAM CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 254 VIETNAM HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 255 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 256 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 257 TAIWAN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 258 TAIWAN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 259 TAIWAN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 260 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 261 TAIWAN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 262 TAIWAN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 263 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 264 TAIWAN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 265 TAIWAN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 266 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 267 TAIWAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 268 TAIWAN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 269 TAIWAN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 270 TAIWAN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 271 TAIWAN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 272 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 273 REST OF ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
그림 목록
FIGURE 1 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET
FIGURE 14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022
FIGURE 15 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND)
FIGURE 16 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022
FIGURE 19 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND)
FIGURE 20 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022
FIGURE 23 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 24 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022
FIGURE 27 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 28 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 32 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030)
FIGURE 39 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
